SCHEMBL6392113

SCHEMBL6392113

O=C(CCCCC(O)c1ccccc1)NO

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 15/20 0.67
HDAC8 Q9BY41 14/20 0.67
HDAC2 Q92769 10/20 0.61
HDAC6 Q9UBN7 9/20 0.61
HDAC5 Q9UQL6 9/20 0.61
HDAC4 P56524 8/20 0.61
HDAC7 Q8WUI4 8/20 0.61
HDAC11 Q96DB2 8/20 0.61
HDAC9 Q9UKV0 8/20 0.61
HDAC3 O15379 8/20 0.61
HDAC10 Q969S8 7/20 0.61
ALOX5 P09917 1/20 0.56
KDM4E B2RXH2 1/20 0.56
BRD4 O60885 1/20 0.56
NCOR1 O75376 1/20 0.56
NR1I2 O75469 1/20 0.56
EGFR P00533 1/20 0.56
CYP3A4 P08684 1/20 0.56
LTA4H P09960 1/20 0.56
NR0B1 P51843 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6138980 0.91 HDAC1 (0.64) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6138796 0.91 HDAC1 (0.64) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL3153981 0.89 HDAC1 (0.54) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6138730 0.88 HDAC1 (0.61) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6388052 0.88 HDAC1 (0.63) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6138725 0.88 HDAC1 (0.61) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6387749 0.87 HDAC1 (0.64) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6138397 0.87 HDAC1 (0.60) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL6138390 0.87 HDAC1 (0.60) HDAC1HDAC8HDAC2HDAC6HDAC5
SCHEMBL12672800 0.84 ASAH1 (0.76) HDAC1HDAC8HDAC2HDAC6HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US claimed
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119305-A1 Il-6 production inhibitors IL6, IL6ST, PADI6 HDAC1 1343/4885HDAC8 1593/4885HDAC2 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.